{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:33:13Z","timestamp":1769880793959,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cld.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T06:55:11Z","timestamp":1682232911000},"page":"649-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonviral or Drug-Induced Etiologies of Acute-on-Chronic Liver Failure (Autoimmune, Vascular, and Malignant)"],"prefix":"10.1016","volume":"27","author":[{"given":"Suzanne A.","family":"Elshafey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Robert S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cld.2023.03.008_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clinre.2018.10.014","article-title":"Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"43","author":"Li","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.03.008_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jceh.2020.08.005","article-title":"A\u00a0nationwide analysis of Budd-Chiari syndrome in the United States","volume":"11","author":"Alukal","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"43","key":"10.1016\/j.cld.2023.03.008_bib3","doi-asserted-by":"crossref","first-page":"16236","DOI":"10.3748\/wjg.v20.i43.16236","article-title":"Budd-Chiari syndrome: a single-center experience","volume":"20","author":"Pavri","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.03.008_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.03.008_bib5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.03.008_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.cld.2023.03.008_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2023.03.008_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2002-33210","article-title":"Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia","volume":"34","author":"Amitrano","year":"2002","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.cld.2023.03.008_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00042737-200503000-00013","article-title":"Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis","volume":"17","author":"Erkan","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.03.008_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.26998","article-title":"Treatment of acute portal vein thrombosis by nontraditional anticoagulation","volume":"60","author":"Martinez","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.03.008_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3350\/cmh.2016.0016","article-title":"Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban","volume":"22","author":"Yang","year":"2016","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.03.008_bib12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.27225","article-title":"Treating thrombosis in cirrhosis patients with new oral agents: ready or not?","volume":"61","author":"Intagliata","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.03.008_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.cld.2023.03.008_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.03.008_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2023.03.008_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"10","key":"10.1016\/j.cld.2023.03.008_bib17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2023.03.008_bib18","first-page":"611","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J\u00a0Dig Dis"},{"issue":"4","key":"10.1016\/j.cld.2023.03.008_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"European association for the study of the liver. EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.03.008_bib20","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.03.008_bib21","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.cgh.2020.10.006","article-title":"Increased mortality risk in autoimmune hepatitis: a nationwide population-based cohort study with histopathology","volume":"19","author":"Sharma","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.03.008_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.03.008_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.cld.2023.03.008_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.03.008_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.03.008_bib26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","author":"Karkhanis","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.03.008_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"Clinical Practice Guidelines Panel, EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.03.008_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12876-017-0730-6","article-title":"A\u00a0rare cause of acute liver failure- a case report","volume":"17","author":"Bernardo","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2023.03.008_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cgh.2014.09.040","article-title":"Malignant infiltration of the liver presenting as acute liver failure","volume":"13","author":"Rich","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:11Z","timestamp":1761069551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1089326123000417"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.03.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonviral or Drug-Induced Etiologies of Acute-on-Chronic Liver Failure (Autoimmune, Vascular, and Malignant)","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}